View in Other Languages à¸‚่าวà¸à¸²à¸£à¸•ลาดออสเตรเลียประจำวันที่ 10 à¸à¸¸à¸¡à¸ à¸²à¸žà¸±à¸™à¸˜à¹Œ 2011: Calzada (ASX:CZD)à¹à¸–ลงผลสำเร็จà¸à¹‰à¸²à¸§à¸«à¸™à¹‰à¸²à¹ƒà¸™à¸à¸²à¸£à¸§à¸´à¸ˆà¸±à¸¢ Human Stem Cell Study For Bone Growth Laporan Pasar Australia 10 Februari 2011: Calzada (ASX:CZD) Mengumumkan Haril Positif dalam Penelitian Stem Cell Manusia untuk Pertumbuhan Tulang 2011å¹´2月10日澳洲股市:Calzada (ASX:CZD)宣布人类骨骼生长干细胞研究å–得积æžç»“æžœ ØªÙ‚رير السوق الاسترالية 10 شباط/ÙØ¨Ø±Ø§ÙŠØ±ØŒ 2011: أعلنت شركة Calzada ASX:CZD نتائج إيجابية لدراسة على الخلايا الجذعية البشرية لتنمية العظام. Reporte del Mercado Australiano del 10 de febrero de 2011: Calzada (ASX:CZD) Anuncia Resultados Positivos En Células Madres Humanas Para Crecimiento de Hueso Australischer Marktbericht, 10. Februar 2011: Calzada (ASX:CZD) verlautbart positive Ergebnisse aus Stammzellen-Studie für Knochenwachstum Australian Market Report of February 10, 2011: Calzada (ASX:CZD) Announce Positive Results In Human Stem Cell Study For Bone Growth ã‚ªãƒ¼ã‚¹ãƒˆãƒ©ãƒªã‚¢å¸‚場レãƒãƒ¼ãƒˆã€€2011å¹´2月10日: Calzada (ASX:CZD) ãŒéª¨ã®æˆé•·ã«é–¢ã™ã‚‹ãƒ’ト幹細胞研究ã§ã®å‰å‘ããªçµæžœã‚’発表 2011ë…„ 2ì›”10ì¼ í˜¸ì£¼ 시장보고서: Calzada (ASX:CZD), 골 성장 관련 ì¸ê°„ ì¤„ê¸°ì„¸í¬ ì—°êµ¬ì˜ ê¸ì •ì  ì„±ê³¼ë³´ê³  2011å¹´2月10日澳洲股市:Calzada (ASX:CZD)宣佈人類骨骼生長干細胞研究å–å¾—ç©æ¥µçµæžœ Relatório do Mercado Australiano de 10 de Fevereiro de 2011: Calzada (ASX:CZD) Anuncia Resultados Positivos em Estudo das Células-Tronco Humanas para o Crescimento Ósseo 
Australian Market Report of February 10, 2011: Calzada (ASX:CZD) Announce Positive Results In Human Stem Cell Study For Bone Growth
Australian Market Report of February 10, 2011: Calzada (ASX:CZD) Announce Positive Results In Human Stem Cell Study For Bone Growth

Sydney, Feb 10, 2011 AEST (ABN Newswire) - Calzada Limited (googlechartASX:CZD) said today that its wholly owned subsidiary Metabolic Pharmaceuticals Pty Ltd had initiated an in vitro study into the effect of AOD9604 on human osteoblasts. AOD9604 performed positively in the study, demonstrating its ability to promote bone growth and to treat diseases such as osteoporosis. Calzada is seeking partnership with pharmaceutical and medical device companies to further develop AOD9604, either as a regulated drug through the traditional pharmaceutical development path or as a cosmetic or nutraceutical with a faster path to market.

PharmAust Limited (googlechartASX:PAA) has signed a binding agreement to purchase 80% interest in a European high grade precious and base metal project, "Luke River". Luke River is an advanced exploration project located in northeast Macedonia. Extensive historical exploration reported high grade precious and base metal mineralisation, with grades up to 16.30g/t gold, 91.50g/t silver, 3.7% lead and 4.0% zinc.

Northern Star Resources Limited (googlechartASX:NST) reported solid production and exploration at its Paulsens gold mine in Western Australia. In January, mining at Paulsens produced 5,957oz gold and gold sales reached 4,946oz, generating revenue of A$6.8 million. Paulsens also returned numerous significant gold intersections of up to 60g/t. The Company plans to announce resource update and new 2011 mine plan in the March Quarter.

Latin Resources Limited (googlechartASX:LRS) has reached an agreement to acquire 14,068 hectares of world class Iron and Heavy Mineral Sands tenements at Guadalupito in Peru. The acquisition adds to the 2,218 hectares already controlled at Guadalupito by the Company's Peruvian subsidiary. Previous drilling at Guadalupito has demonstrated its potential for multi commodity project including Magnetite, Gold, Andalusite, Ilmenite, Zircon, Rare Earths and Tungsten.

Contact

Asia Business News
Tel: +61-2-9247-4344
http://www.abnnewswire.net


ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 31) (Last 30 Days: 119) (Since Published: 15260) 

View in Other Languages 2441018535184551709216383155061526014454139181333412609 (179956)

googlechart